Indication

Hypoxic Ischemic

1 clinical trial

1 product

1 drug

Clinical trial

Effect of ALlopurinol in Addition to Hypothermia for Hypoxic-ischemic Brain Injury on Neurocognitive Outcome - a Blinded Randomized Placebo-controlled Parallel Group Multicenter Trial for Superiority (Phase III)

Status: Recruiting, Estimated PCD: 2026-01-31

Drug

Product